ID   HPC-Y0
AC   CVCL_6912
AS   CVCL_A067
SY   HPC-YO; HPCY0
DR   cancercelllines; CVCL_6912
DR   Cosmic; 730529
DR   Wikidata; Q54890252
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C7977; Pancreatic acinar cell carcinoma
DI   ORDO; Orphanet_424046; Acinar cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R.,
RA   Saeger H.-D.;
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=2208167;
RA   Yamaguchi N., Yamamura Y., Koyama K., Ohtsuji E., Imanishi J.,
RA   Ashihara T.;
RT   "Characterization of new human pancreatic cancer cell lines which
RT   propagate in a protein-free chemically defined medium.";
RL   Cancer Res. 50:7008-7014(1990).
//
RX   PubMed=7961102; DOI=10.1111/j.1349-7006.1994.tb02898.x; PMCID=PMC5919355;
RA   Suwa H., Yoshimura T., Yamaguchi N., Kanehira K., Manabe T.,
RA   Imamura M., Hiai H., Fukumoto M.;
RT   "K-ras and p53 alterations in genomic DNA and transcripts of human
RT   pancreatic adenocarcinoma cell lines.";
RL   Jpn. J. Cancer Res. 85:1005-1014(1994).
//